Recently, it has been shown that inhibition of CA4 effects relaxation of skeletal muscles both in model organisms (Wetzel et al., 2002; Tricarico et al., 2004) and human cells (Eguchi et al., 2006), suggesting their importance as potential drug targets in neuromuscular diseases. This evidence concerns the gene CA4 and neuromuscular disease.